跳至主要内容
临床试验/JPRN-UMIN000052217
JPRN-UMIN000052217已完成4 期

Efficacy of 0.1% Xylometazoline-Hydrochloride nasal decongestant spray in Post-operative sign/symptom relief following Septoplasty: A Prospective-experimental Study. - Efficacy of 0.1% Xylometazoline-Hydrochloride Nasal Decongestant Spray in Post-septoplasty Sign/Symptom Relief (ENSPS-EPES).

one.0 个研究点目标入组 106 人开始时间: 2023年9月15日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
one.
入组人数
106

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15years-old 至 60years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients not from UH and CGH of age <15 years and >60 years, admitted for revision surgery or trauma or in which septoplasty was performed along with other nasal procedures like turbinate reduction or functional endoscopic sinus surgery or submucosal resection (SMR), history of acute or chronic rhinosinusitis and obstructive sleep apnoea, perforated nasal septum, insufficient nasal valve, granulomatous condition of the nose and sinuses, pregnancy, craniofacial malformation (cleft palate or cleft lip), HIV or any bleeding diathesis condition, malignancy, allergic rhinitis, usage of antihistamines or anticoagulants, and history of allergies to allocated drugs were excluded from the study.

研究者

发起方
one.

相似试验